Loratadine Impurity 13, with the CAS number 201466-35-5, is a chemical compound that is recognized as an impurity associated with the antihistamine drug loratadine. This substance is typically characterized by its molecular structure, which may include specific functional groups that differentiate it from the parent compound. Impurities like Loratadine Impurity 13 are often identified during the synthesis and quality control processes of pharmaceutical manufacturing, as they can affect the efficacy and safety of the final product. The compound may exhibit distinct physical and chemical properties, such as solubility, stability, and reactivity, which are crucial for understanding its behavior in formulations. Analytical techniques like HPLC (High-Performance Liquid Chromatography) and NMR (Nuclear Magnetic Resonance) spectroscopy are commonly employed to characterize such impurities. Regulatory guidelines often require the identification and quantification of impurities to ensure compliance with safety standards in pharmaceutical products. Overall, the presence of impurities like Loratadine Impurity 13 highlights the importance of rigorous quality control in drug development.

Loratadine Impurity 13

201466-35-5: Loratadine Impurity 13, with the CAS number 201466-35-5, is a chemical compound that is recognized as an impurity associated with the antihistamine drug loratadine. This substance is typically characterized by its molecular structure, which may include specific functional groups that differentiate it from the parent compound. Impurities like Loratadine Impurity 13 are often identified during the synthesis and quality control processes of pharmaceutical manufacturing, as they can affect the efficacy and safety of the final product. The compound may exhibit distinct physical and chemical properties, such as solubility, stability, and reactivity, which are crucial for understanding its behavior in formulations. Analytical techniques like HPLC (High-Performance Liquid Chromatography) and NMR (Nuclear Magnetic Resonance) spectroscopy are commonly employed to characterize such impurities. Regulatory guidelines often require the identification and quantification of impurities to ensure compliance with safety standards in pharmaceutical products. Overall, the presence of impurities like Loratadine Impurity 13 highlights the importance of rigorous quality control in drug development.

CAS 201466-35-5

Loratadine Impurity 13

Loratadine Impurity 1

Ref: 4Z-L-1052